Diversity of genotype and mode of spread of Hepatitis C virus in Northern India
- PMID: 21727729
- PMCID: PMC3133980
- DOI: 10.4103/1319-3767.82576
Diversity of genotype and mode of spread of Hepatitis C virus in Northern India
Abstract
Background/aim: Hepatitis C is caused by hepatitis C virus (HCV), which is classified into 6 genotypes. It leads to chronic hepatitis in 80% of the cases. Genotype of the virus helps in predicting response to antiviral therapy and also the duration of treatment. Therefore, it is important to know the prevalence of each genotype. Knowledge regarding the route of entry of HCV in the blood is also necessary to formulate a strategy to prevent its spread.
Patients and methods: One hundred and two newly diagnosed patients with chronic hepatitis C, having anti-HCV antibody-positive were included in the study. Their HCV RNA viral load and genotype were determined by Reverse Transcriptase PCR assay on Roche Cobas Ampliprep analyzer.
Results: Genotype 3 was commonly detected in 58.8% patients followed by genotype 1 in 20.6%. Twelve patients had genotype 4 (11.8%) and 9 had mixed infection with genotypes 3 and 4. Among these patients, 43.1% of patients had a history of multiple injection exposure. Blood transfusion received by 6.9% and 2.9% had donated blood. Only 1 patient had a history of drug abuse.
Conclusion: The distribution of genotypes varies in different regions and therefore its knowledge is important, as it determines the response of the patient to the treatment. The use of autodisabled syringes, their proper disposal, following biomedical waste management guidelines, and organizing continued medical education and workshops will help in preventing the spread of HCV infection.
Conflict of interest statement
Comment in
-
How can we reduce the burden of Hepatitis C?Saudi J Gastroenterol. 2011 Jul-Aug;17(4):227-8. doi: 10.4103/1319-3767.82572. Saudi J Gastroenterol. 2011. PMID: 21727726 Free PMC article. No abstract available.
References
-
- WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6:35–47. - PubMed
-
- Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis. 1995;15:5–14. - PubMed
-
- Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–50. - PubMed
-
- Takabashi M, Yamada G, Miyamota R, Doi T, Endo H, Taujii T. Natural course of chronic hepatitis C. Am J Gastroenterol. 1993;88:240–3. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources